Main Article Content
Viscum album extract suppresses cell proliferation and induces apoptosis in bladder cancer cells
Abstract
Purpose: To evaluate the effect of Viscum album (VA) extract on the progression of bladder cancer (BC) and its effect on the proliferation and apoptosis of T24 and J82 bladder cancer cells.
Methods: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT assay) was conducted to examine the proliferation of bladder cancer cells. Flow cytometry (FCM) was employed to assess changes in the cell cycle of bladder cancer cells. The expression levels of proliferating cell nuclear antigen (PCNA), CLND1 (cyclin D1), p21, and p27 in control and VA extract-treated (100, 200, or 300 μg/mL) T24 and J82 cells were measured by immunoblot assay. The effects of VA extract on T24 or J82 cell apoptosis were evaluated using FCM. Immunoblot assay was performed to evaluate Bcl2, Bax, and cleaved caspase 3 expression in control or VA extract-treated bladder cancer cells. In addition, the effect of VA extract on Axl-AKT pathways was also evaluated by immunoblot assay.
Results: Viscum album extract treatment significantly blocked bladder cancer cell proliferation and induced cell cycle arrest. In addition, VA extract stimulated bladder cancer cell apoptosis. Moreover, this study found that VA extract suppressed Axl-AKT pathways in bladder cancer.
Conclusion: Viscum album extract exerts anti-proliferation and pro-apoptosis effects on bladder cancer cells. These abilities render Viscum album extract as promising agent in bladder cancer treatment.